Aclaris Therapeutics Inc (ACRS)
Healthcare
Biotechnology
5.50 $
+6.3%
vs. previous close
Closing price · As of: 3. Aug 2026
Aclaris Therapeutics Inc (ACRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -18 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -21 | -25 | -6.8 | -21 | -12 | 22 | -8.9 | -13 | -10.0 | -11 | -13 | -18 | -52 | |
| 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.5 | |
| 6.5 | 5.9 | 1.3 | 2.1 | 2.9 | 3.0 | 2.9 | 3.5 | 3.1 | 2.9 | 2.9 | 3.2 | 12 | |
| 5.0 | 7.6 | – | – | – | – | – | – | – | – | – | – | – | |
| 3.7 | -3.2 | 13 | -9.0 | -4.7 | 26 | -1.0 | -1.9 | 0.8 | 0.6 | 3.2 | -1.6 | 3.0 | |
| 0.2 | 0.1 | 0.4 | 0.1 | 0.0 | 0.0 | 36 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| -20 | 33 | 7.6 | 17 | -0.7 | 2.8 | -89 | 19 | 5.0 | 14 | 10 | -31 | -1.7 | |
| 27 | -0.1 | 0.1 | -0.1 | 0.0 | 0.0 | -0.3 | -0.3 | 0.0 | 0.3 | -0.2 | – | – | |
| 27 | -0.1 | 0.0 | -0.1 | 0.0 | 0.0 | 75 | -0.3 | 0.0 | -3.0 | -2.5 | 58 | 52 | |
| -14 | 7.9 | 0.8 | -4.0 | -13 | 25 | -23 | 5.8 | -5.0 | -0.1 | -5.3 | 8.7 | -1.7 | |
| -21 | -25 | -7.2 | -21 | -12 | 22 | -45 | -14 | -10 | -11 | -13 | -18 | -52 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.